An impact evaluation of two rounds of mass drug administration on the prevalence of active trachoma: A clustered cross sectional survey.

An impact evaluation of two rounds of mass drug administration on the prevalence of active trachoma: A clustered cross sectional survey.

INTRODUCTION:We investigated the impact of two round of mass drug administration on trachoma prevalence in Plateau and Nasarawa States of Nigeria. The mass drug administration was conducted as a component of the SAFE Strategy, a combination of interventions recommended for the global elimination of...

Full description

Bibliographic Details
Main Authors:	Asrat Genet Amnie, Paul Emerson, Deborah McFarland, Jonathon King, Emmanuel Miri, Lisa Dickman
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC6114510?pdf=render

Similar Items

Correction: An impact evaluation of two rounds of mass drug administration on the prevalence of active trachoma: A clustered cross sectional survey.
by: Asrat Genet Amnie, et al.
Published: (2019-01-01)

Prevalence of Trachoma in Car-Nicobar Island, India after Three Annual Rounds of Mass Drug Administration with Azithromycin.
by: Sumit Malhotra, et al.
Published: (2016-01-01)

Mass drug administration for trachoma: how long is not long enough?
by: Violeta Jimenez, et al.
Published: (2015-03-01)

Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal
by: Emma M. Harding-Esch, et al.
Published: (2019-10-01)

Children as agents of change in trachoma control
by: Berhanu Melek, et al.
Published: (2013-05-01)

Trachoma prevalence after discontinuation of mass azithromycin distribution
by: Godwin, W, et al.
Published: (2020)

Changes in trachoma indicators in Kiribati with two rounds of azithromycin mass drug administration, measured in serial population-based surveys.
by: E Brook Goodhew, et al.
Published: (2023-07-01)

Prevalence of trachoma in the Kayes region of Mali eight years after stopping mass drug administration.
by: Lamine Traoré, et al.
Published: (2018-02-01)

The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children.
by: Jennifer S Lee, et al.
Published: (2014-04-01)

Serology for trachoma surveillance after cessation of mass drug administration.
by: Diana L Martin, et al.
Published: (2015-02-01)

Mass treatment with azithromycin for trachoma control: participation clusters in households.
by: Elizabeth N Ssemanda, et al.
Published: (2010-10-01)

The prevalence of blinding trachoma in northern states of Sudan.
by: Awad Hassan, et al.
Published: (2011-01-01)

Stopping azithromycin mass drug administration for trachoma: A systematic review.
by: Hamidah Mahmud, et al.
Published: (2021-07-01)

Azithromycin mass treatment for trachoma control: risk factors for non-participation of children in two treatment rounds.
by: Elizabeth N Ssemanda, et al.
Published: (2012-01-01)

Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
by: Emma M Harding-Esch, et al.
Published: (2013-01-01)

Prevalence of Active and Latent Yaws in the Solomon Islands 18 Months after Azithromycin Mass Drug Administration for Trachoma.
by: Michael Marks, et al.
Published: (2016-08-01)

Monitoring of mass distribution interventions for trachoma in Plateau State, Nigeria.
by: Elizabeth A Cromwell, et al.
Published: (2013-01-01)

Prevalence and associated factors of active trachoma among children aged 1-9 years old in mass drug administration graduated and non-graduated districts in Northwest Amhara region, Ethiopia: A comparative cross-sectional study.
by: Gashaw Melkie, et al.
Published: (2020-01-01)

Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
Published: (2013-06-01)

Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia.
by: Emma M. Harding-Esch, et al.
Published: (2013-06-01)

Correction: Prevalence of Active and Latent Yaws in the Solomon Islands 18 Months after Azithromycin Mass Drug Administration for Trachoma.
by: PLOS Neglected Tropical Diseases Staff
Published: (2018-03-01)

A cost-analysis of conducting population-based prevalence surveys for the validation of the elimination of trachoma as a public health problem in Amhara, Ethiopia.
by: Randall P Slaven, et al.
Published: (2020-09-01)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
by: Abdou Amza, et al.
Published: (2021-01-01)

Where do we go from here? Prevalence of trachoma three years after stopping mass distribution of antibiotics in the regions of Kayes and Koulikoro, Mali.
by: Sanoussi Bamani, et al.
Published: (2010-01-01)

Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial.
by: Jeremy D Keenan, et al.
Published: (2019-06-01)

Relationship between Community Drug Administration Strategy and Changes in Trachoma Prevalence, 2007 to 2013.
by: Bette Liu, et al.
Published: (2016-07-01)

Emerging themes in coping with lifetime stress and implication for stress management education
by: Asrat G Amnie
Published: (2018-06-01)

Baseline trachoma prevalence in Guinea: Results of national trachoma mapping in 31 health districts.
by: André Géopogui, et al.
Published: (2018-06-01)

What will happen if we do nothing to control trachoma: health expectancies for blinding trachoma in southern Sudan.
by: Jeremiah M Ngondi, et al.
Published: (2009-01-01)

Integrating an NTD with one of "The big three": combined malaria and trachoma survey in Amhara Region of Ethiopia.
by: Paul M Emerson, et al.
Published: (2008-01-01)

Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control
by: Ebrima Bojang, et al.
Published: (2017-03-01)

The cost of antibiotic mass drug administration for trachoma control in a remote area of South Sudan.
by: Jan H Kolaczinski, et al.
Published: (2011-10-01)

The burden of trachoma in Ayod County of Southern Sudan.
by: Jonathan D King, et al.
Published: (2008-09-01)

Current status of trachoma elimination in Africa
by: T. Gebre, et al.
Published: (2020-12-01)

The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing
by: Thomas M. Lietman, et al.
Published: (2015-06-01)

Trachoma prevalence in rural areas of eastern Iran
by: J. Sharifi-Rad, et al.
Published: (2016-05-01)

Short-Term Malaria Reduction by Single-Dose Azithromycin during Mass Drug Administration for Trachoma, Tanzania
by: Stephen E. Schachterle, et al.
Published: (2014-06-01)

Trachoma then and now: update on mapping and control
by: Anthony W Solomon, et al.
Published: (2018-01-01)

Progress and projections in the program to eliminate trachoma.
by: Paul M Emerson, et al.
Published: (2017-04-01)

Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community.
by: Athumani M Ramadhani, et al.
Published: (2019-07-01)